- Home
- HCWB
HCWB
HCW Biologics Inc.
as 07-26-2024 4:00pm EST
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | MIRAMAR |
| Market Cap: | 41.2M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 10.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.76 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.55 - $2.19 | Next Earning Date: | 08-09-2024 |
| Revenue: | $1,162,574 | Revenue Growth: | 43.63% |
| Revenue Growth (this year): | 105.23% | Revenue Growth (next year): | N/A |
Latest HCW Biologics Inc. News
HCWB Breaking Stock News: Dive into HCWB Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 months ago
HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
4 months ago
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
Simply Wall St.
5 months ago
Rebecca Byam Bought 122% More Shares In HCW Biologics
Market Exclusive
6 months ago
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
GlobeNewswire
6 months ago
LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®
Simply Wall St.
6 months ago
Several Insiders Invested In HCW Biologics Flagging Positive News
Business Wire
6 months ago
Organigram Announces the First Tranche Closing from BAT Investment
Zacks
6 months ago
AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal
Compare HCWB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HCWB HCW Biologics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.